GL1X · GenesisL1 explorer

Research workbench

Cryoem reconstruction of cowpea mosaic virus (cpmv) bound to an affimer reagent

Analyse Cryoem reconstruction of cowpea mosaic virus (cpmv) bound to an affimer reagent in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6QOZ
Type
protein
Length
2,307 residues
Chains
9
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA2 polyprotein; Cowpea mosaic virus large subunit; Affimer binding protein
UniProt
P03599
Pockets
20 · best druggability 0.79

Structure

electron microscopy · 3 distinct chains · 10% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, D, F, HRNA2 polyproteinprotein1896% helix, 44% strandP03599
B, E, G, ICowpea mosaic virus large subunitprotein36810% helix, 40% strandP03599
CAffimer binding proteinprotein7924% helix, 53% strand—

Pockets

20 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18390.790.8282empty
27090.750.8068empty
32170.660.8424empty
42490.630.8138empty
52130.630.8228empty

Interfaces

17 interfaces between chains.

  • A–B · 1783 Ų buried · 20 hydrogen bonds · protein-protein
  • F–G · 1781 Ų buried · 20 hydrogen bonds · protein-protein
  • H–I · 1781 Ų buried · 20 hydrogen bonds · protein-protein
  • D–E · 1779 Ų buried · 20 hydrogen bonds · protein-protein
  • F–H · 1694 Ų buried · 26 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 isopeptide (isopeptide).

Compared structures

  • 6QOZ · CryoEM reconstruction of Cowpea Mosaic Virus (CPMV) bound to an Affimer reagent · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.